跳转至内容
Merck
CN

32422

Supelco

头孢噻呋 盐酸盐

VETRANAL®, analytical standard

别名:

(6R,7R)-7-{[(2Z)-2-(2-氨基-4-噻唑基)-2-(甲氧亚氨基)乙酰基]氨基}-3-{[(2-呋喃甲酰基)硫代]甲基}-8-氧-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 盐酸盐, 3-[(2-呋喃羰基)硫代]甲基]-7-[2-(2-氨基-4-噻唑基)-2-(甲氧基亚氨基乙酰胺基)-3-头孢烯-4-羧酸 盐酸盐

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C19H17N5O7S3 · HCl
化学文摘社编号:
103980-44-5
分子量:
560.02
MDL编号:
MFCD04038020
UNSPSC代码:
41116107
PubChem化学物质编号:
329754200
NACRES:
NA.24

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

analytical standard

质量水平

100

产品线

VETRANAL®

保质期

limited shelf life, expiry date on the label

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

forensics and toxicology
pharmaceutical (small molecule)

包装形式

neat

SMILES字符串

Cl.CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c4csc(N)n4

InChI

1S/C19H17N5O7S3.ClH/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10;/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28);1H/b23-11-;/t12-,16-;/m1./s1

InChI key

KEQFDTJEEQKVLM-JUODUXDSSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

应用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

其他说明

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

法律信息

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

11 - Combustible Solids

WGK

WGK 3

法规信息

涉药品监管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCL2502
BCCH1294
BCCB8697
BCBZ8753
BCBS3479V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

J E Dechant et al.
Journal of veterinary pharmacology and therapeutics, 36(2), 122-129 (2012-04-11)
Six adult male alpacas received one subcutaneous administration of ceftiofur crystalline free acid (CCFA) at a dosage of 6.6 mg/kg. After a washout period, the same alpacas received three subcutaneous doses of 6.6 mg/kg CCFA at 5-day intervals. Blood samples
M L Macpherson et al.
Journal of veterinary pharmacology and therapeutics, 36(1), 59-67 (2012-03-28)
The objective of this study was to determine the pharmacokinetics of CCFA in mares with placentitis and evaluate the disposition of the drug in fetal fluids, fetal membranes, colostrum, and serum of foals. A secondary objective was to obtain pilot
L Oliveira et al.
Journal of dairy science, 95(4), 1913-1920 (2012-03-31)
Antimicrobials are often used for treatment of bovine mastitis and the possibility of selection for resistant bacteria must be considered. The objectives of this study were to determine the minimum inhibitory concentration of Staphylococcus aureus recovered from cases of clinical
Katharine L Hope et al.
American journal of veterinary research, 73(5), 620-627 (2012-04-27)
To determine the pharmacokinetic properties of 1 IM injection of ceftiofur crystalline-free acid (CCFA) in American black ducks (Anas rubripes). 20 adult American black ducks (6 in a preliminary experiment and 14 in a primary experiment). Dose and route of
Pharmacokinetics of a continuous rate infusion of ceftiofur sodium in normal foals.
J M G Wearn et al.
Journal of veterinary pharmacology and therapeutics, 36(1), 99-101 (2012-05-23)
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持